| Product Code: ETC9959597 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Artificial Intelligence in Medicine Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Artificial Intelligence in Medicine Market - Industry Life Cycle |
3.4 United States (US) Artificial Intelligence in Medicine Market - Porter's Five Forces |
3.5 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Artificial Intelligence in Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of technology in healthcare |
4.2.2 Growing demand for personalized medicine and precision healthcare |
4.2.3 Rising prevalence of chronic diseases requiring advanced diagnostics and treatment |
4.2.4 Government initiatives and funding for AI in healthcare |
4.2.5 Technological advancements in artificial intelligence and machine learning algorithms |
4.3 Market Restraints |
4.3.1 Concerns regarding data privacy and security |
4.3.2 High initial investment and implementation costs |
4.3.3 Resistance from healthcare professionals towards adopting AI technologies |
4.3.4 Lack of regulatory frameworks and standards for AI in healthcare |
4.3.5 Potential bias and lack of transparency in AI algorithms |
5 United States (US) Artificial Intelligence in Medicine Market Trends |
6 United States (US) Artificial Intelligence in Medicine Market, By Types |
6.1 United States (US) Artificial Intelligence in Medicine Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Hardware, 2021- 2031F |
6.1.4 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Software, 2021- 2031F |
6.1.5 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Service, 2021- 2031F |
6.2 United States (US) Artificial Intelligence in Medicine Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Deep Learning, 2021- 2031F |
6.2.3 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Querying Method, 2021- 2031F |
6.2.4 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Natural Language Processing, 2021- 2031F |
6.2.5 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Context Aware Processing, 2021- 2031F |
6.3 United States (US) Artificial Intelligence in Medicine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.3.3 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Clinical Research Trial, 2021- 2031F |
6.3.4 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.3.5 United States (US) Artificial Intelligence in Medicine Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Artificial Intelligence in Medicine Market Import-Export Trade Statistics |
7.1 United States (US) Artificial Intelligence in Medicine Market Export to Major Countries |
7.2 United States (US) Artificial Intelligence in Medicine Market Imports from Major Countries |
8 United States (US) Artificial Intelligence in Medicine Market Key Performance Indicators |
8.1 Patient outcomes improvement rate |
8.2 Reduction in diagnostic errors and misdiagnoses |
8.3 Increase in efficiency and speed of healthcare delivery |
8.4 Adoption rate of AI-powered medical devices and software by healthcare providers |
8.5 Number of successful clinical trials and research studies utilizing AI technologies in medicine |
9 United States (US) Artificial Intelligence in Medicine Market - Opportunity Assessment |
9.1 United States (US) Artificial Intelligence in Medicine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Artificial Intelligence in Medicine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Artificial Intelligence in Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Artificial Intelligence in Medicine Market - Competitive Landscape |
10.1 United States (US) Artificial Intelligence in Medicine Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Artificial Intelligence in Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here